Probiotic Efficacy in Postmenopausal Women with Bacterial Vaginosis

Recruiting now · Not applicable · Has a placebo group

Conditions studied: Bacterial Vaginosis (BV), Menopause

In brief

This study is a double-blind, randomized, controlled trial (RCT) aimed at evaluating the effects of Lactobacillus sp. probiotic administration on the vaginal microbiota changes in postmenopausal women with bacterial vaginosis and how its affect to immunology profile. Postmenopausal women diagnosed with bacterial vaginosis will be recruited as subjects as long as collected period in this study. All patients will receive Metronidazole antibiotic treatment then blind-randomly be divided into two groups: the treatment group, receiving Floragyn® probiotic tablets (Lapi, Indonesia), and the placebo group, receiving Cal 95® (Lapi, Indonesia). As a control, postmenopausal women without bacterial vaginosis will also be included and receive Floragyn® probiotic tablets only.

Key facts

Study ID
NCT06659380
Run by
Hasanuddin University
People needed
12
Starts
2024-06-26
Expected to finish
2024-12-31
Last updated by the study team
2024-10-28

Who can join

Age: any. Sex: female. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.